Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302561 · ClinicalTrials.gov registry record · NA
Galactooligosaccharide, Immune Strength, and Digestive Health in Older Adults Over Cold and Flu Season
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 84
- Enrollment target
NCT01302561 is a NA study that has completed, run by University of Florida. The registered enrollment target is 84 participants.
The verdict
NCT01302561, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine whether a functional fiber, galactooligosaccharide, can help maintain immune strength and digestive health in free-living older adults. It is hypothesized that older adults consuming the fiber daily for 24 weeks over cold and flu season will have more healthy days due to a proliferation of beneficial bacteria within the colon which alters cytokine production and enhances natural killer cell function. Immune and gastrointestinal health will be evaluated via daily questionnaires obtained from 80 participants and from the collection of blood and fecal samples.
Interventions
- DIETARY_SUPPLEMENT Sucrose
- DIETARY_SUPPLEMENT Galactooligosaccharide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01302561
The ClinicalTrials.gov registry entry for NCT01302561 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sucrose is the first listed.
NCT01302561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01302561 about?
NCT01302561 is a clinical study titled "Galactooligosaccharide, Immune Strength, and Digestive Health in Older Adults Over Cold and Flu Season". The purpose of this research study is to determine whether a functional fiber, galactooligosaccharide, can help maintain immune strength and digestive health in free-living older adults. It is hypothesized that older adults consuming the fiber daily for 24 weeks over cold and flu season will have mo...
What is the current status of trial NCT01302561?
This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2010-10. Estimated completion is 2011-04.
What interventions are being tested in trial NCT01302561?
The interventions under investigation include: Sucrose (DIETARY_SUPPLEMENT), Galactooligosaccharide (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01302561?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.